200
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Cytogenetically masked CBFB-MYH11 fusion and concomitant TP53 deletion in a case of acute myeloid leukemia with a complex karyotype

ORCID Icon, ORCID Icon, ORCID Icon, , , , , , , ORCID Icon & show all
Pages 1772-1774 | Received 02 Jan 2020, Accepted 07 Mar 2020, Published online: 29 Mar 2020

References

  • Duployez N, Boudry-Labis E, Roumier C, et al. SNP-array lesions in core binding factor acute myeloid leukemia. Oncotarget. 2018;9(5):6478–6489.
  • Duployez N, Marceau-Renaut A, Boissel N, et al. Comprehensive mutational profiling of core binding factor acute myeloid leukemia. Blood. 2016;127(20):2451–2459.
  • Douet-Guilbert N, Chauveau A, Gueganic N, et al. Acute myeloid leukaemia (FAB AML-M4Eo) with cryptic insertion of cbfb resulting in cbfb-Myh11 fusion. Hematol Oncol. 2017;35(3):385–389.
  • Faber ZJ, Chen X, Gedman AL, et al. The genomic landscape of core-binding factor acute myeloid leukemias. Nat Genet. 2016;48(12):1551–1556.
  • Opatz S, Bamopoulos SA, Metzeler KH, et al. The clinical mutatome of core binding factor leukemia. Leukemia [Internet]. 2020 [cited 2020 Feb 26]. Available from: http://www.nature.com/articles/s41375-019-0697-0.
  • Schnittger S, Bacher U, Haferlach C, et al. Rare CBFB-MYH11 fusion transcripts in AML with inv(16)/t(16;16) are associated with therapy-related AML M4eo, atypical cytomorphology, atypical immunophenotype, atypical additional chromosomal rearrangements and low white blood cell count: a study on 162 patients. Leukemia. 2007;21:725–731.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.